2022 Q3 Form 10-Q Financial Statement
#000089467122000020 Filed on August 15, 2022
Income Statement
Concept | 2022 Q3 | 2022 Q2 | 2022 Q1 |
---|---|---|---|
Revenue | $12.53M | $11.22M | $10.66M |
YoY Change | 11.63% | 0.2% | -4.22% |
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | |||
YoY Change | |||
% of Gross Profit | |||
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | |||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | |||
YoY Change | |||
Operating Profit | |||
YoY Change | |||
Interest Expense | $687.0K | $668.0K | $667.0K |
YoY Change | -20.76% | -32.11% | -38.13% |
% of Operating Profit | |||
Other Income/Expense, Net | |||
YoY Change | |||
Pretax Income | $4.491M | $2.353M | $5.048M |
YoY Change | 24.75% | -30.73% | 18.72% |
Income Tax | $801.0K | $354.0K | $923.0K |
% Of Pretax Income | 17.84% | 15.04% | 18.28% |
Net Earnings | $3.690M | $1.999M | $4.125M |
YoY Change | 21.38% | -30.13% | 16.82% |
Net Earnings / Revenue | 29.44% | 17.81% | 38.71% |
Basic Earnings Per Share | $0.77 | $0.42 | $0.87 |
Diluted Earnings Per Share | $773.3K | $418.9K | $866.4K |
COMMON SHARES | |||
Basic Shares Outstanding | 4.772M | 4.772M | 4.772M |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2022 Q3 | 2022 Q2 | 2022 Q1 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | |||
YoY Change | |||
Cash & Equivalents | $113.1M | $94.09M | $163.7M |
Short-Term Investments | |||
Other Short-Term Assets | |||
YoY Change | |||
Inventory | |||
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | |||
YoY Change | |||
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $21.66M | $20.74M | $21.72M |
YoY Change | -1.55% | -6.14% | -2.62% |
Goodwill | $7.319M | $7.319M | |
YoY Change | |||
Intangibles | $35.00K | $44.00K | |
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $7.654M | $5.728M | $435.0K |
YoY Change | 1813.5% | 1332.0% | -27.5% |
Total Long-Term Assets | |||
YoY Change | |||
TOTAL ASSETS | |||
Total Short-Term Assets | |||
Total Long-Term Assets | |||
Total Assets | $1.252B | $1.254B | $1.258B |
YoY Change | 0.57% | 1.37% | 2.69% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | |||
YoY Change | |||
Accrued Expenses | $22.94M | $20.98M | $19.72M |
YoY Change | 9.26% | 6.49% | 0.6% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | |||
YoY Change | |||
Long-Term Debt Due | $530.0K | $531.0K | $1.031M |
YoY Change | -66.88% | -66.81% | -67.78% |
Total Short-Term Liabilities | $23.47M | $21.51M | $20.75M |
YoY Change | 3.87% | 0.98% | -9.0% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $26.59M | $10.11M | $9.607M |
YoY Change | 195.39% | 12.31% | 13.02% |
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | $26.59M | $10.11M | $9.607M |
YoY Change | 195.39% | 12.31% | 13.02% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $23.47M | $21.51M | $20.75M |
Total Long-Term Liabilities | $26.59M | $10.11M | $9.607M |
Total Liabilities | $1.124B | $1.121B | $1.122B |
YoY Change | 1.76% | 2.16% | 3.14% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | $106.8M | $104.1M | |
YoY Change | |||
Common Stock | $57.19M | $57.19M | |
YoY Change | |||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | $16.67M | $16.67M | |
YoY Change | |||
Treasury Stock Shares | $693.9K | $693.9K | |
Shareholders Equity | $128.6M | $132.6M | $136.6M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $1.252B | $1.254B | $1.258B |
YoY Change | 0.57% | 1.37% | 2.69% |
Cashflow Statement
Concept | 2022 Q3 | 2022 Q2 | 2022 Q1 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | $3.690M | $1.999M | $4.125M |
YoY Change | 21.38% | -30.13% | 16.82% |
Depreciation, Depletion And Amortization | |||
YoY Change | |||
Cash From Operating Activities | $5.119M | $2.547M | $2.563M |
YoY Change | 27.66% | -24.64% | 271.45% |
INVESTING ACTIVITIES | |||
Capital Expenditures | -$714.0K | -$746.0K | -$202.0K |
YoY Change | 78.5% | 239.09% | 12.22% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $15.04M | -$68.20M | -$3.498M |
YoY Change | 612.84% | 7.54% | -488.67% |
Cash From Investing Activities | $14.33M | -$68.95M | -$3.700M |
YoY Change | 732.97% | 8.34% | -613.89% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -429.0K | -3.227M | 12.83M |
YoY Change | -110.44% | -135.58% | -65.06% |
NET CHANGE | |||
Cash From Operating Activities | 5.119M | 2.547M | 2.563M |
Cash From Investing Activities | 14.33M | -68.95M | -3.700M |
Cash From Financing Activities | -429.0K | -3.227M | 12.83M |
Net Change In Cash | 19.02M | -69.63M | 11.69M |
YoY Change | 93.26% | 36.02% | -69.33% |
FREE CASH FLOW | |||
Cash From Operating Activities | $5.119M | $2.547M | $2.563M |
Capital Expenditures | -$714.0K | -$746.0K | -$202.0K |
Free Cash Flow | $5.833M | $3.293M | $2.765M |
YoY Change | 32.27% | -8.53% | 217.82% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022Q2 | us-gaap |
Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
|
844000 | |
CY2022Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4771774 | |
CY2021Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4787446 | |
CY2022Q2 | us-gaap |
Federal Home Loan Bank Advances General Debt Obligations Disclosures Maximum Amount Available
FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable
|
100000000 | |
ovbc |
Cash Management Advances Maturity Period
CashManagementAdvancesMaturityPeriod
|
P90D | ||
CY2022Q2 | us-gaap |
Federal Home Loan Bank Advances General Debt Obligations Disclosures Amount Of Available Unused Funds
FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresAmountOfAvailableUnusedFunds
|
100000000 | |
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000894671 | ||
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4766453 | ||
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4787446 | ||
CY2022Q2 | us-gaap |
Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
|
1507000 | |
CY2022Q2 | us-gaap |
Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
|
297000 | |
CY2022Q2 | us-gaap |
Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
|
231000 | |
us-gaap |
Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
|
287000 | ||
us-gaap |
Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
|
0 | ||
CY2021Q2 | us-gaap |
Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
|
-30000 | |
us-gaap |
Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
|
60000 | ||
CY2021Q4 | us-gaap |
Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
|
1993000 | |
CY2021Q4 | us-gaap |
Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
|
10000 | |
CY2021 | us-gaap |
Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
|
10000 | |
CY2021 | us-gaap |
Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
|
0 | |
us-gaap |
Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
|
0 | ||
CY2022Q2 | us-gaap |
Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
|
0 | |
us-gaap |
Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
|
0 | ||
CY2021Q2 | us-gaap |
Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
|
0 |